Sinonasal mucosal melanoma: A 13-year experience at a single institution

Skull Base

Volumn 19, Issue 4, 2009, Pages 255-262

  Narasimhan, Kailash ^a,b   Kucuk, Omer ^a,b   Lin, Ho Sheng ^a,b   Heilbrun, Lance K ^b   Carron, Michael ^a,b   Venkatramanamoorthy, Raghu ^b   Mathog, Robert ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Melanoma; Nasal cavity; Sinonasal mucosal melanoma; Sinus

Indexed keywords

ALPHA INTERFERON; ANTIINFECTIVE AGENT; CARBOPLATIN; CISPLATIN; RECOMBINANT INTERLEUKIN 12; TAMOXIFEN; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VELTANE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CENTER; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE DURATION; DISEASE FREE SURVIVAL; DRUG MEGADOSE; EPISTAXIS; FEMALE; FRONTAL SINUS; HUMAN; LOW DRUG DOSE; MALE; MAXILLA RESECTION; MAXILLARY SINUS; MELANOMA; NECK DISSECTION; NOSE CAVITY; ORBIT; OVERALL SURVIVAL; PARANASAL SINUS TUMOR; PRIORITY JOURNAL; RECURRENT DISEASE; SINONASAL MOCUSAL MELANOMA; SINONASAL MUCOSAL MELANOMA; SKULL; SKULL BASE; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 67650434704     PISSN: 15315010     EISSN: 15320065     Source Type: Journal    
DOI: 10.1055/s-0028-1115321     Document Type: Article

References (17)

1. Thompson AC, Morgan DA, Bradley PJ. Malignant melanoma of the nasal cavity and paranasal sinuses. Clin Otolaryngol 1993;18:34-36 (Pubitemid 23092608)
2. Conley JJ, Ackerman AB. Melanoma of the Head and Neck. 1st ed. New York: Georg Thieme Verlag; 1990: 154-178
3. Thompson LDR, Wienke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003;27(5):594-611 (Pubitemid 36514471)
4. Cheng YF, Lai CC, Ho CY, Shu CH, Lin CZ. Toward a better understanding of sinonasal mucosal melanoma: clinical review of 23 cases. J Chin Med Assoc 2007; 70(1):24-29 (Pubitemid 46218239)
5. Lee E. Statistical Methods for Survival Data Analysis. 3rd ed. Hoboken, New Jersey: Wiley & Sons, Inc.; 2003: 76-91
6. Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and a report of 14 patients. Cancer 1997;80(8):1373-1386 (Pubitemid 27441010)
7. Holmstrom M, Lund VJ. Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde. Br J Ind Med 1991;48(1):9-11
8. Barrett AW, Scully C. Human oral mucosal melanocytes: a review. J Oral Pathol Med 1994;23:97-103 (Pubitemid 2074672)
9. Wick MR, Stanley SJ, Swanson PE. Immunohistochemical diagnosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and anti-synaptophysin. Arch Pathol Lab Med 1988;112:616-620 (Pubitemid 18157214)
10. Koops HS, Vaglini M, Suciu S, et al. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. J Clin Oncol 1998;16(9):2906-2912
11. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14(1): 7-17 (Pubitemid 26019991)
12. Kirkwood JM, Ibrahim J, Lawson DH, et al. High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696. J Clin Oncol 2001;19(5): 1430-1436 (Pubitemid 32202550)
13. Hancock BW, Wheatley K, Harris S, et al. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study-United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon alfa-2a in high-risk resected malignant melanoma. J Clin Oncol 2004;22(1):53-61 (Pubitemid 41095114)
14. Kingdom TT, Kaplan M. Mucosal melanoma of the nasal cavity and paranasal sinuses. Head Neck 1995;17(3): 184-189
15. Gilligan D, Slevin NJ. Radical radiotherapy for 23 cases of mucosal melanoma in the nasal cavity and paranasal sinuses. Br J Radiol 1991;64:1147-1150
16. Lund VJ, Howard DJ, Harding L, Wei WI. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999;109(2 Pt 1):208-211 (Pubitemid 29075560)
17. Brandwein MS, Rothstein A, Lawson W, Bodian C, Urken ML. Sinonasal melanoma: a clinicopathologic study of 25 cases and literature meta-analysis. Arch Otolaryngol Head Neck Surg 1997;123(3):290-296 (Pubitemid 27123992)